Li J#, Yang D#, Lv R#, Jin Y#, Wang M#, Chen Y, Pan X, Yang M, Qin X, Gu X, Yang B, Mou Y, Yu L, You D, Li J, Fan K, Li J, He Q, Deng Y, Jiang D*, Chen Y*, Chen C*. Single-cell mapping of extrachromosomal circular DNA architecture and evolution in cutaneous squamous cell carcinoma. Cancer Lett. 2026;218735. doi: 10.1016/j.canlet.2026.218735. PMID: 42457020. (IF=11.8).

Chen Y, Zhao H, Wang L, Li L, Liu R, Jiang Y, Tang P, Li Y, Ni J, Tao D*, Li J*, Peng J*. CLWD: a Chinese histopathology dataset for lung adenocarcinoma subtype classification. Sci Data. 2026 Mar 5;13(1):599. doi: 10.1038/s41597-026-06906-z. PMID: 41786798; PMCID: PMC13079772. (IF=9.8).

Xu C#, Xia P#, Li J#, Lewis KB, Ciombor KK, Wang L, Smith JJ, Beauchamp RD, Chen XS. Discovery and validation of a 10-gene predictive signature for response to adjuvant chemotherapy in stage II and III colon cancer. Cell Rep Med. 2024 Aug 20;5(8):101661. doi: 10.1016/j.xcrm.2024.101661. Epub 2024 Jul 25. PMID: 39059386. (IF=16.9).

Li J#, Chen J#, Sun X#, Yang H#, Sun K, Liu C, Wang Y, Xu M, Ji X, Zhang J, Wu X, Wang A, Fan B, Zhang X, Wu Y, Cui P, Peng J, Zhao Y, Wu W, Yu H, Bu Z, Ji J, Lan X. Uncovering chromatin accessibility and cancer diagnostic potential via cell-free DNA utilization. Sci Bull (Beijing). 2024;69:2987-2992. doi: 10.1016/j.scib.2024.04.013. PMID: 38664094. (IF=20.6).

Li J#, Sun X, Yang H, Chen J, Bu Z, Ji J, Lan X*. Integrated analysis toolkit for dissecting whole-genome-wide features of cell-free DNA. Clin Transl Med. 2023 Mar;13(3):e1212. doi: 10.1002/ctm2.1212. (IF=11.492).

Pang H#, Jiang Y#, Li J#, Wang Y#, Nie M#, Xiao N, Wang S, Song Z, Ji F, Chang Y, Zheng Y, Yao K, Yao L, Li S, Li P, Song L*, Lan X*, Xu Z*, Hu Z*. Aberrant NAD+ metabolism underlies Zika virus-induced microcephaly. Nat Metab. 2021 Aug;3(8):1109-1124. doi: 10.1038/s42255-021-00437-0. Epub 2021 Aug 12. (IF=27.5).

Chen J#, Sun Y#, Li J#, Lyu M#, Yuan L#, Sun J, Chen S, Hu C, Wei Q, Xu Z, Guo T, Cheng X. In-depth metaproteomics analysis of tongue coating for gastric cancer: a multicenter diagnostic research study. Microbiome. 2024 Jan 8;12(1):6. doi: 10.1186/s40168-023-01730-8. PMID: 38191439; PMCID: PMC10773145. (IF=16.837).

Li J#, Wang W#, Xia P#, Wan L#, Zhang L, Yu L, Wang L, Chen X*, Xiao Y*, Xu C*. Identification of a five-lncRNA signature for predicting the risk of tumor recurrence in patients with breast cancer. Int J Cancer. 2018 Nov 1;143(9):2150-2160. doi: 10.1002/ijc.31573. (IF=7.396).

Jie Li, Xun Lan*. Perspective on new cell-free DNA technologies for early cancer detection. Cancer Biol Med. 2024 Feb;21(2):139-143. doi: 10.20892/j.issn.2095-3941.2023.0159. Epub 2023 Aug 8. (IF=12.4).

Li J#, Xu M#, Peng J#, Wang J, Zhao Y, Wu W, Lan X*. Novel technologies in cfDNA analysis and potential utility in clinic. Chin J Cancer Res. 2021 Dec 31;33(6):708-718. doi: 10.21147/j.issn.1000-9604.2021.06.07. (IF=7).

Li J#,*, Pan X#, Bi Y#, Huang J, Peng J, Bai C*, Hou J*, Chen Y*. Comprehensive multi-omics analysis of tandem duplicator phenotypes in non-small cell lung cancer. Front Med (Lausanne). 2025 Jun 4;12:1556840. doi: 10.3389/fmed.2025.1556840. PMID: 40534701; PMCID: PMC12174438. (IF=3.1).

Jiang Y, He J, He B, Liu L, Wang L, Li H, Li Y, Shi Y, Liu R, Tang P, Li Y, Du J, Peng J*, Li J*, Chen Y*. Assessing large language model for automated diagnosis of benign and malignant lung tumors. Pathol Res Pract. 2026 Jan;277:156306. doi: 10.1016/j.prp.2025.156306. Epub 2025 Nov 25. PMID: 41308357. (IF=3.0).

Zheng Q, Wang L, Zhang Y, Peng J, Hou J, Wang H, Ma Y, Tang P, Li Y, Li H, Chen Y, Li J*, Chen Y*. Immune Microenvironment Characterization and Machine Learning-Guided Identification of Diagnostic Biomarkers for Ulcerative Colitis. J Inflamm Res. 2025 Jul 9;18:8977-8992. doi: 10.2147/JIR.S526325. PMID: 40661186; PMCID: PMC12256701. (IF=4.1).

Chen Y, Zheng Q, Wang H, Tang P, Deng L, Li P, Li H, Hou J, Li J*, Wang L*, Peng J*. Integrating transcriptomics and proteomics to analyze the immune microenvironment of cytomegalovirus-associated ulcerative colitis and identify relevant biomarkers. BioData Min. 2024 Aug 27;17(1):26. doi: 10.1186/s13040-024-00382-0. PMID: 39192288; PMCID: PMC11348729. (IF=4.0).

Xiaolu Zhang, Jingwei Li, Xun Lan*, Jie Li*. Cell-free DNA-associated multi-feature applications in cancer diagnosis and treatment. Clin Transl Discov. 2024;4:e280. doi: 10.1002/ctd2.280. (IF=1.9).

Tian C, Dong Y, Sun X, Xu L, Ma X, Tao Y, Wang F, Zhang H, Li J, Li K, Chen Y, Liu H, Lan X. Integrative scATAC-seq and mtDNA mutation analysis reveals disease-driven regulatory aberrations in AML. Sci Bull (Beijing). 2025 Oct 15;70(19):3215-3232. doi: 10.1016/j.scib.2025.07.009. Epub 2025 Jul 16. PMID: 40781032. (IF=20.6).

Zhu W#, Mou Y#, Yu L#, Fan K#, Chen K, Duan R, Ye J, Huang S*, Li J*, Chen C*. Cell-free DNA analysis for cancer management: Technologies, features, and clinical translation. Mol Digit Med. 2026;1(1):100005. doi: 10.1016/j.mdmed.2026.100005. (IF=暂无).

Liu C#, Zhou Y#, Xu L#, Qin X#, Guan Z, Liu T, Tian C, Li J, Gu F, Lan X*. Deciphering microenvironmental heterogeneity by scalable Niche Guided Module Discovery. Commun Biol. 2026 May 13. doi: 10.1038/s42003-026-10240-w. (IF=5.2).

Ying Yang, Wei Zeng, Xin Wei, Juan Li, Xuelian Chen, Zuyi Zhou, Bo Yang*, Jie Li*, Li Li*. Identification of immune-infiltrated and stroma-enriched subtypes in HER2+ breast cancer. Clin Transl Discov. 2026;6:e70169. doi: 10.1002/ctd2.70169. (IF=1.9).

Xu C#, Qi R#, Ping Y#, Li J, Zhao H, Wang L, Du MY, Xiao Y*, Li X*. Systemically identifying and prioritizing risk lncRNAs through integration of pan-cancer phenotype associations. Oncotarget. 2017 Feb 14;8(7):12041-12051. doi: 10.18632/oncotarget.14510. (IF=暂无).

Xu C#*, Ping Y#, Zhao H#, Ning S, Xia P, Wang W, Wan L, Li J, Zhang L, Yu L, Xiao Y*. LncNetP, a systematical lncRNA prioritization approach based on ceRNA and disease phenotype association assumptions. Oncotarget. 2017 Dec 8;8(68):114603-114612. doi: 10.18632/oncotarget.23059. (IF=暂无).

Wang S#, Xia P#, Zhang L#, Yu L#, Liu H, Meng Q, Liu S, Li J, Song Q, Wu J, Wang W, Yang L*, Xiao Y*, Xu C*. Systematical Identification of Breast Cancer-Related Circular RNA Modules for Deciphering circRNA Functions Based on the Non-Negative Matrix Factorization Algorithm. Int J Mol Sci. 2019 Feb 20;20(4):919. doi: 10.3390/ijms20040919. (IF=4.9).

Wang X, Chen H, Jiang R, Hong X, Peng J, Chen W, Jiang J, Li J, Huang D, Dai H, Wang W, Lu J, Zhao Y, Wu W. Interleukin-17 activates and synergizes with the Notch signaling pathway in the progression of pancreatic ductal adenocarcinoma. Cancer Lett. 2021 Jun 28;508:1-12. doi: 10.1016/j.canlet.2021.03.003. (IF=10.1).